Navigation Links
Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Date:12/8/2007

well-tolerated and may represent a benefit for patients in terms of convenience and ease of administration. Tanespimycin is clearly an active and manageable agent and is deserving of further clinical study."

"We continue to see meaningful antitumor activity and tolerability with the tanespimycin plus bortezomib combination in multiple myeloma across patient populations. In addition, we are observing intriguing evidence supporting the hypothesis that in the tanespimycin/bortezomib combination, tanespimycin may be exerting a neuroprotective effect based on the observation of reduced neuropathy, a side effect associated with bortezomib," said Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and Chief Executive Officer. "The data from this ongoing trial are still being evaluated, and multiple patients remain on study. At this time, the overall response rate appears to be lower than previously reported. We are investigating whether there were patient characteristics that may have contributed to this lower response rate, including the possibility that patients added to the study since the data were last reported represented a more advanced and heavily pretreated population. We will complete the study and further evaluate the data in consultation with multiple myeloma experts to confirm the most expeditious course forward. Taken as a whole, the currently available data from this trial suggest that there may be utility in adjusting the TIME program to optimize the therapeutic potential of the tanespimycin and bortezomib combination. We have not, however, made any definitive decisions concerning a potential adjustment."

Tanespimycin Phase 1b Trial Results

The objective of the Phase 1b dose-escalating trial was to evaluate tanespimycin with bortezomib in patients with relapsed, refractory multiple myeloma, relative to safety, pharmacokinetic, pharmacodynamic and anti-myeloma effects. Dose escalations in the entire trial ranged from 100-340 mg/m2 for
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... opportune time to find the best plan at the ... Through the end of the year, thousands ... about their health coverage. This is when the ... benefits they will sign up and pay for in ... part of this decision, says Independent Retail Pharmacist Steve ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Surgical and Medical Instrument Manufacturing Industry ...
(Date:12/15/2009)... Dec. 15 Waters Corporation (NYSE: ... Publisher(TM) (v.7.1 SR4), an electronic laboratory notebook solution ... a secure electronic repository that stores and manages ... database and is used to boost efficiency in ... the SAFE-BioPharma digital identity and signature standard. The ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 1Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hema 6741 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 1BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 2BIO key 28R 29 Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 10989 3Mario Badescu 26apos 3Bs Acne Spot Treatment Picked as ELLE Readers 26apos 3B Favorite 62569 1
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... on anti-arrhythmia data from the MERLIN,TIMI-36 study, have ... Cardiology (ESC) Congress 2007 taking place in Vienna, ... update session entitled, The Effect of Ranolazine, a,Novel ...
... Genetic testing can be,used to help personalize the ... research published in the,September 1, 2007, issue of ... This result represents one of the first applications ... medical care., Because individuals metabolize drugs differently, ...
Other Medicine Technology:CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3Genetics Determine Optimal Drug Dose of Common Anticoagulant 2Genetics Determine Optimal Drug Dose of Common Anticoagulant 3
(Date:12/15/2009)... flu were worse, ,we would have really been in ... -- The outbreak of the pandemic H1N1 swine flu ... respond to public health emergencies, a new report says. ... Health and the Robert Wood Johnson Foundation, also finds ... health system. , "The 2009 H1N1 outbreak is the ...
(Date:12/15/2009)... some sobering statistics concerning the parallel rise in diabetes and obesity ... means of combating this trend afflicting their workforce. , ... ... are climbing across America due in large part to the alarming ... Association has stated that the rate of diabetes could be cut ...
(Date:12/15/2009)... be leaders in the fight against malaria ... in online learning, the Masie Center and Blackboard ... ONE and Malaria No More announced ... "Malaria Griots" program, a dynamic education course that ... in the fight against malaria. ,, "In ...
(Date:12/15/2009)... BERWYN, Pa., Dec. 15 4R Systems, ... supply chain solutions which help retailers significantly increase ... chain decisions, announced today that The Vitamin Shoppe ... 2008. ,, "4R,s store and DC inventory solutions ... inventory efficiency and in-stocks over the last two ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4
... report by a UN official, warns the Asia-Pacific countries of ... The report also states that such an epidemic can only ... more to keep the younger generation off drugs. ... body fighting HIV/AIDS at least 70 per cent of HIV ...
... early stage of breast cancer, according to researchers. This could ... they reported in The Lancet Oncology journal. ,Ductal ... the milk ducts. This is a form of pre-cancer that ... outside. The usual way of treating such a pre-cancer is ...
... increase the number of seats in existing facilities to fill ... accommodate// the central government's proposed quota policy, says Chief Minister ... in medical institutions and open more institutes in the state," ... 4,000 doctors and this was the only to "adjust the ...
... cartels operating from Pakistan and Jammu and Kashmir, warns ... always been a transit point for illegal drug consignments ... Afghanistan and Pakistan", said Prafulsinh Sarvaiya, Superintendent of NCB., ... underworld gangs have now become a part of this ...
... Recent research in California has revealed that DDT can ... to the pesticide//. ,While DDT is currently banned ... expand its use to combat mosquitoes that spread malaria. ... of epidemiology and maternal and child health at the ...
... a new survey millions of British tourists face several health ... or anti malaria pills before they go abroad//. ... visited tropical countries on holiday over the last five years ... has claimed over a million lives worldwide each year, 16 ...
Other Medicine News:Health News:Developmental Delays in Infants Linked to DDT 2Health News:Tourists Face Health Risks by Missing Vaccinations 2
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... its new multifunctional lithotripsy system Lithoskop. ... data management is the perfect symbiosis ... Lithoskop is an engineering masterpiece for ... applications like lithotripsy, endourology, urodiagnostics, percutaneous ...
... stimulator for the treatment of long bone ... stimulator is a useful adjunct for the ... planned or when patient compliance may be ... surgically implanted, patients are assured of therapeutic ...
... cataract surgery following refractive surgery grows larger ... for surgeons, as calculating IOL power for ... power following RK, ALK, PRK and LASIK ... or topography. For example, keratometry and simulated ...
Medicine Products: